Multiple cell types within the tumor microenvironment (TME), including cancer, immune, and stromal cells, produce and respond to IFN-Is [11,34]; however, most studies describe ISGs within the tumor bulk not distinguishing between expression among the cell populations. This evidence concerns the gene IFNA1 and neoplasm.